Clinical Trial Update: Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intraperitoneal antibiotics and molgramostim versus intravenous antibiotics for perforated appendicitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendicitis
• Perforated Appendicitis

Drugs mentioned

• Fosfomycin (Fosfomycin)
• METRONIDAZOLE (Metronidazole)
• Molgramostim (granulocyte-macrophage colony-stimulating factor (GM-CSF))

Snippet

Sponsor: Herlev Hospital | Conditions: Appendicitis Perforated | Phase 2 | Status: COMPLETED